Login to Your Account



Other News To Note


Tuesday, October 23, 2012
• Ligand Pharmaceuticals Inc., of San Diego, said it will receive a $2 million milestone payment from Merck & Co. Inc., of Whitehouse Station, N.J., under the terms of a development and license collaboration for the development of dinaciclib.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription